About
Optogenetic Platform
Areas of Focus
Categories
Middle East
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
53
By Phase
PHASE1/PHASE2: 1PHASE4: 1
By Status
RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06306638Collaborator
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
PHASE1/PHASE2Recruiting
53 participants
Started: Oct 1, 2024 · Completed: Oct 1, 2029
NCT04075136Collaborator
Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy
PHASE4Withdrawn
Started: Mar 30, 2023 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Ramat Gan, Israel
Map
Loading map...